-transparent.png){kind=logo}
The metabolic interaction between carbamazepine (CBZ) and haloperidol (HP) was studied in Japanese schizophrenic patients treated with HP but not with CBZ and with both CBZ and HP. The serum CBZ concentrations in patients treated without HP were significantly decreased (p < 0.05), on average approximately 40%, as compared to those in patients treated with both CBZ and HP, whereas the serum HP concentrations in patients treated with both HP and CBZ were significantly decreased (p < 0.05), as compared to those in patients treated with HP but not with CBZ. The effect of HP, which prevents the serum CBZ level from decreasing, was shown in this study.
Related Publications
K Iwahashi, and
R Miyatake, and
H Suwaki, and
K Hosokawa, and
Y Ichikawa
April 1985,
Journal of clinical psychopharmacology,
K Iwahashi, and
R Miyatake, and
H Suwaki, and
K Hosokawa, and
Y Ichikawa
August 1999,
Journal of clinical psychopharmacology,
K Iwahashi, and
R Miyatake, and
H Suwaki, and
K Hosokawa, and
Y Ichikawa
May 1986,
The American journal of psychiatry,
K Iwahashi, and
R Miyatake, and
H Suwaki, and
K Hosokawa, and
Y Ichikawa
July 1990,
Biopharmaceutics & drug disposition,
K Iwahashi, and
R Miyatake, and
H Suwaki, and
K Hosokawa, and
Y Ichikawa
May 1996,
The Annals of pharmacotherapy,
K Iwahashi, and
R Miyatake, and
H Suwaki, and
K Hosokawa, and
Y Ichikawa
May 1983,
Acta paediatrica Scandinavica,
K Iwahashi, and
R Miyatake, and
H Suwaki, and
K Hosokawa, and
Y Ichikawa
January 1995,
L'Encephale,
K Iwahashi, and
R Miyatake, and
H Suwaki, and
K Hosokawa, and
Y Ichikawa
December 1984,
Developmental medicine and child neurology,
K Iwahashi, and
R Miyatake, and
H Suwaki, and
K Hosokawa, and
Y Ichikawa
July 1981,
Acta physiologica Scandinavica,
K Iwahashi, and
R Miyatake, and
H Suwaki, and
K Hosokawa, and
Y Ichikawa
June 2007,
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
